Cell repopulation and overall treatment time
- PMID: 2211245
- DOI: 10.1016/0360-3016(90)90036-j
Cell repopulation and overall treatment time
Abstract
Prolongation of the overall treatment time in radiotherapy, especially of squamous cell carcinomas of the head and neck, decreases the chances of cure. This is most likely because of the proliferation of surviving clonogenic tumor cells between dose fractions. Between the 3rd and 7th week of conventional radiotherapy of head and neck cancers, on average 0.5 to 0.7 Gy are lost per day by repopulation. As this represents an average value, repopulation may be even more efficient in subgroups of faster tumors. There is little information on repopulation rates during the first 2 weeks of radiotherapy. Prolongation of the overall treatment time in radiotherapy helps to avoid severe side effects from acutely responding tissues, especially oral mucosa. This sparing effect of increasing overall treatment time is mainly caused by the regeneration of mucosal stem cells and transit cells. This repopulation is slow in the first 2 weeks and accelerates dramatically thereafter. The nature of the trigger for acceleration is not known but seems to be related to a critical threshold of acute tissue hypoplasia and the development of the inflammatory reaction of the connective tissue. It is not known whether accelerated tumor repopulation is stimulated by the same or a similar mechanism as the normal epithelium. During accelerated repopulation the oral mucosa is able to compensate a considerably higher proportion of the daily dose fraction than the tumor. These factors have to be taken into account when treatment strategies are designed to cope with the problem of accelerated repopulation.
Comment in
-
Cell repopulation and overall treatment time.Int J Radiat Oncol Biol Phys. 1991 Sep;21(4):1108-9. doi: 10.1016/0360-3016(91)90765-v. Int J Radiat Oncol Biol Phys. 1991. PMID: 1917615 No abstract available.
Similar articles
-
Modulation of repopulation processes in oral mucosa: experimental results.Int J Radiat Biol. 2003 Jul;79(7):531-7. doi: 10.1080/09553002310001600925. Int J Radiat Biol. 2003. PMID: 14530162 Review.
-
Accelerated repopulation: friend or foe? Exploiting changes in tumor growth characteristics to improve the "efficiency" of radiotherapy.Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1377-83. doi: 10.1016/0360-3016(91)90301-j. Int J Radiat Oncol Biol Phys. 1991. PMID: 1938539
-
The hazard of accelerated tumor clonogen repopulation during radiotherapy.Acta Oncol. 1988;27(2):131-46. doi: 10.3109/02841868809090333. Acta Oncol. 1988. PMID: 3390344
-
Derivation of the optimum dose per fraction from the linear quadratic model.Br J Radiol. 1995 Aug;68(812):894-902. doi: 10.1259/0007-1285-68-812-894. Br J Radiol. 1995. PMID: 7551788
-
Time factor for acute tissue reactions following fractionated irradiation: a balance between repopulation and enhanced radiosensitivity.Int J Radiat Biol. 2003 Jul;79(7):513-24. doi: 10.1080/09553000310001600907. Int J Radiat Biol. 2003. PMID: 14530160 Review.
Cited by
-
Potential prevention: Aloe vera mouthwash may reduce radiation-induced oral mucositis in head and neck cancer patients.Chin J Integr Med. 2012 Aug;18(8):635-40. doi: 10.1007/s11655-012-1183-y. Epub 2012 Aug 2. Chin J Integr Med. 2012. PMID: 22855041 Review.
-
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocol.Vet Comp Oncol. 2022 Sep;20(3):623-631. doi: 10.1111/vco.12815. Epub 2022 Apr 3. Vet Comp Oncol. 2022. PMID: 35338766 Free PMC article.
-
The Quest for Optimal Fractionation Schedules in Stereotactic Radiotherapy.Cureus. 2020 Jan 26;12(1):e6777. doi: 10.7759/cureus.6777. Cureus. 2020. PMID: 32117663 Free PMC article. Review.
-
Cell death-stimulated cell proliferation: a tissue regeneration mechanism usurped by tumors during radiotherapy.Semin Radiat Oncol. 2013 Oct;23(4):288-95. doi: 10.1016/j.semradonc.2013.05.003. Semin Radiat Oncol. 2013. PMID: 24012343 Free PMC article. Review.
-
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells.Int J Mol Sci. 2021 Oct 1;22(19):10671. doi: 10.3390/ijms221910671. Int J Mol Sci. 2021. PMID: 34639012 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials